FDA

Lawsuits challenge the implementation of Obamacare.

Now that Howard Shelanski is confirmed, he faces choices about his priorities.

Using retrospective drug safety data can improve patient care.

Confirmation hearing for OIRA nominee, Supreme Court takings decision, CFPB offers exemptions, and more…

Agency report indicates that potentially anti-competitive drug settlements are on the rise.

Obama’s next OIRA Administrator should act to embed retrospective evaluation into the regulatory process.

U.S. government takes measures to protect public from excessive sun exposure.

What can the efforts of a single former OIRA official teach about making broad institutional changes?

Obama signs executive order to share government information, Republicans block EPA nominee, and more.

Law promises to promote transparency and encourage technological innovation.

Supreme Court will not hear tobacco labeling case, Administration releases new drug policy, and more.

FTC cracks down on cell phone cramming, gun control bill hits wall in Senate, and more.